News
To strengthen its U.S. presence, Roche is building up inventory, ramping up production at three of its U.S. plants and relocating one manufacturing site to the U.S. through a technology transfer, its ...
During the three-day visit, the Swiss delegation will highlight Switzerland’s substantial investments in the United States, ...
Investing.com - European equity indices mainly slipped lower Thursday as the relief rally stalled, with investors digesting a ...
Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...
FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by ...
Swiss drugmaker Roche said on Thursday its first-quarter sales rose 7% to 15.44 billion Swiss francs ($18.64 billion) and it ...
Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana. Roche, a Swiss company, ...
Latin Times on MSN11h
$50B U.S. Push Swiss Pharma Leader Roche Fights Tariff ThreatsRoche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...
Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...
Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results